{"id":59349,"date":"2026-09-16T12:41:23","date_gmt":"2026-09-16T10:41:23","guid":{"rendered":"https:\/\/editing.capitalmind.com\/?post_type=deals&p=59349"},"modified":"2026-09-16T15:47:58","modified_gmt":"2026-09-16T13:47:58","slug":"cession-de-deux-centres-ophtalmologiques-a-sanoptis","status":"publish","type":"deals","link":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","title":{"rendered":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis"},"content":{"rendered":"\n

Investec a conseill\u00e9 les propri\u00e9taires de l’Augenzentrum Interlaken<\/em> et de l’Augenzentrum Frutigen<\/em> dans le cadre de la cession d’une participation majoritaire \u00e0 Sanoptis.<\/strong><\/p>\n\n\n\n

A propos du deal<\/h2>\n\n\n\n

Investec a conseill\u00e9 les deux propri\u00e9taires des centres ophtalmologiques suisses Augenzentrum Interlaken et Augenzentrum Frutigen dans le cadre de leur cession respective \u00e0 Sanoptis.<\/p>\n\n\n\n

Ces deux soci\u00e9t\u00e9s affili\u00e9es proposent toute la gamme des soins ophtalmologiques conservateurs et chirurgicaux, y compris les traitements non urgents. L\u2019\u00e9quipe, compos\u00e9e de trois m\u00e9decins et d\u2019environ 15 collaborateurs, prend en charge plus de 10 000 patients et r\u00e9alise 1 000 interventions chirurgicales par an.<\/p>\n\n\n\n

Sanoptis est un groupe europ\u00e9en de premier plan dans le domaine de l’ophtalmologie, dont le si\u00e8ge social est situ\u00e9 en Suisse et qui est pr\u00e9sent dans six pays europ\u00e9ens. Avec plus de 5 000 collaborateurs et environ 1 000 m\u00e9decins r\u00e9partis sur pr\u00e8s de 500 sites, le groupe r\u00e9alise 4 millions de traitements chirurgicaux et non chirurgicaux par an.<\/p>\n\n\n\n

Notre r\u00f4le<\/h2>\n\n\n\n

L’\u00e9quipe d’Investec a conseill\u00e9 les propri\u00e9taires d’Augenzentrum Interlaken et d’Augenzentrum Frutigen tout au long du processus de fusion-acquisition, jusqu’\u00e0 la conclusion de la transaction, notamment :<\/p>\n\n\n\n

    \n
  • \u00c9laboration du business plan<\/em> et des supports marketing<\/li>\n\n\n\n
  • Identification des acqu\u00e9reurs potentiels (strat\u00e9giques et financiers)<\/li>\n\n\n\n
  • Approche du march\u00e9 et mise en \u0153uvre d\u2019un processus de vente concurrentiel<\/li>\n\n\n\n
  • Pr\u00e9paration et gestion de la due diligence<\/em><\/li>\n\n\n\n
  • Conduite des n\u00e9gociations<\/li>\n\n\n\n
  • Accompagnement dans la n\u00e9gociation des documents juridiques<\/li>\n\n\n\n
  • Coordination de toutes les parties concern\u00e9es, y compris les conseillers juridiques et fiscaux<\/li>\n<\/ul>\n\n\n
    \n
    \n
    \n \n
    \n \u201c\u201d<\/span>\n\n

    Avec Investec, nous avons trouv\u00e9 un conseiller qui non seulement nous a apport\u00e9 un soutien technique comp\u00e9tent dans notre recherche d’un partenaire adapt\u00e9 \u00e0 nos entreprises, mais qui nous a \u00e9galement accompagn\u00e9s tout au long du processus avec assurance, dans une d\u00e9marche ax\u00e9e sur les solutions et avec le tact n\u00e9cessaire, m\u00eame dans des situations difficiles.<\/p>\n

    Gr\u00e2ce \u00e0 la grande expertise d’Investec, \u00e0 son engagement et \u00e0 son approche orient\u00e9e vers les objectifs, nous avons pu aboutir \u00e0 une transaction id\u00e9ale avec un partenaire compatible sur le plan culturel et pertinent sur le plan strat\u00e9gique.<\/p>\n

    Nous avons grandement appr\u00e9ci\u00e9 le soutien d\u2019Investec et la collaboration avec son \u00e9quipe tout au long du processus de transaction, et nous continuerons \u00e0 choisir Investec comme conseiller \u00e0 l\u2019avenir.<\/p>\n<\/div> \n\n – Dr phil. II Andreas Wild, fondateur et propri\u00e9taire, Augenzentrum Interlaken \/ Augenzentrum Frutigen<\/cite>\n <\/blockquote>\n <\/div>\n <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

    Investec a conseill\u00e9 les propri\u00e9taires de l’Augenzentrum Interlaken et de l’Augenzentrum Frutigen dans le cadre de la cession d’une participation…<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3768],"dealtype":[3706],"clienttype":[3729],"class_list":["post-59349","deals","type-deals","status-publish","hentry","sector-healthcare-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"yoast_head":"\nCession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Investec a conseill\u00e9 les propri\u00e9taires des centres ophtalmologiques suisses dans le cadre de leur cession \u00e0 Sanoptis\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory\" \/>\n<meta property=\"og:description\" content=\"Investec a conseill\u00e9 les propri\u00e9taires des centres ophtalmologiques suisses dans le cadre de leur cession \u00e0 Sanoptis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-16T13:47:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/\",\"name\":\"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#website\"},\"datePublished\":\"2026-09-16T10:41:23+00:00\",\"dateModified\":\"2026-09-16T13:47:58+00:00\",\"description\":\"Investec a conseill\u00e9 les propri\u00e9taires des centres ophtalmologiques suisses dans le cadre de leur cession \u00e0 Sanoptis\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/deals\\\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cession de deux centres ophtalmologiques \u00e0 Sanoptis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\\\/\\\/www.investec.com\\\/advisory\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/capitalmind---corporate-finance-advisory\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory","description":"Investec a conseill\u00e9 les propri\u00e9taires des centres ophtalmologiques suisses dans le cadre de leur cession \u00e0 Sanoptis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","og_locale":"fr_FR","og_type":"article","og_title":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory","og_description":"Investec a conseill\u00e9 les propri\u00e9taires des centres ophtalmologiques suisses dans le cadre de leur cession \u00e0 Sanoptis","og_url":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","og_site_name":"Investec Business Advisory","article_modified_time":"2026-09-16T13:47:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","url":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/","name":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis | Investec Business Advisory","isPartOf":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#website"},"datePublished":"2026-09-16T10:41:23+00:00","dateModified":"2026-09-16T13:47:58+00:00","description":"Investec a conseill\u00e9 les propri\u00e9taires des centres ophtalmologiques suisses dans le cadre de leur cession \u00e0 Sanoptis","breadcrumb":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.investec.com\/advisory\/fr\/deals\/cession-de-deux-centres-ophtalmologiques-a-sanoptis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.investec.com\/advisory\/fr\/"},{"@type":"ListItem","position":2,"name":"Cession de deux centres ophtalmologiques \u00e0 Sanoptis"}]},{"@type":"WebSite","@id":"https:\/\/www.investec.com\/advisory\/fr\/#website","url":"https:\/\/www.investec.com\/advisory\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investec.com\/advisory\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.investec.com\/advisory\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/www.investec.com\/advisory\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.investec.com\/advisory\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/www.investec.com\/advisory\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/www.investec.com\/advisory\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/deals\/59349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/media?parent=59349"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/dt?post=59349"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/sector?post=59349"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/dealtype?post=59349"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/www.investec.com\/advisory\/fr\/wp-json\/wp\/v2\/clienttype?post=59349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}